JMP Securities Remains a Hold on The RMR Group (RMR)
JMP Securities analyst Mitchell Germain maintained a Hold rating on The RMR Group (RMR – Research Report) today. The company’s ...
HCI Group price target raised to $150 from $145 at JMP Securities
JMP Securities raised the firm’s price target on HCI Group (HCI) to $150 from $145 and keeps a Market Perform rating on the shares ...
Maplebear (NASDAQ:CART) Price Target Raised to $51.00
Maplebear (NASDAQ:CART – Get Free Report) had its price objective lifted by research analysts at JMP Securities from $42.00 to $51.00 in a note issued to investors on Wednesday,Benzinga reports. The ...
Fintel on MSN3d
JMP Securities Downgrades agilon health (AGL)
Fintel reports that on November 11, 2024, JMP Securities downgraded their outlook for agilon health (NYSE:AGL) from Market ...
ETF Daily News1d
Taysha Gene Therapies (NASDAQ:TSHA) Receives Market Outperform Rating from JMP Securities
JMP Securities’ price target suggests a potential upside of ... 00 target price on shares of Taysha Gene Therapies in a report on Tuesday. Canaccord Genuity Group decreased their price objective on ...
Hosted on MSN6d
JMP Securities Downgrades Nerdy (NRDY)
Fintel reports that on November 8, 2024, JMP Securities downgraded their outlook for Nerdy ... The firm decreased its ...
Nasdaq6d
HCI Group price target raised to $150 from $145 at JMP Securities
JMP Securities raised the firm’s price target on HCI Group (HCI) to $150 from $145 and keeps a Market Perform rating on the shares following “better-than-expected” results. The firm ...
SciELO15d
Infections in Heart Failure - Impact on Mortality
In the present study, the authors show a group of inpatients with severe decompensated HF, who require high doses of inotropes, which makes the analysis of the real impact of sepsis/septic shock ...